Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Identifieur interne : 003619 ( PubMed/Curation ); précédent : 003618; suivant : 003620

Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Auteurs : Michael S. Sabel [États-Unis] ; Kent A. Griffith ; Alisha Arora ; Josef Shargorodsky ; Dan G. Blazer ; Riley Rees ; Sandra L. Wong ; Vincent M. Cimmino ; Alfred E. Chang

Source :

RBID : pubmed:17560249

Descripteurs français

English descriptors

Abstract

With the introduction of sentinel lymph node (SLN) biopsy for melanoma, inguinal lymph node dissections (ILND) are more commonly performed for microscopic disease than for clinically palpable disease. We sought to examine the effect this change has on the morbidity of the operation.

DOI: 10.1016/j.surg.2006.12.018
PubMed: 17560249

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:17560249

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.</title>
<author>
<name sortKey="Sabel, Michael S" sort="Sabel, Michael S" uniqKey="Sabel M" first="Michael S" last="Sabel">Michael S. Sabel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Surgical Oncology, Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.msabel@umich.edu </nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Division of Surgical Oncology, Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Griffith, Kent A" sort="Griffith, Kent A" uniqKey="Griffith K" first="Kent A" last="Griffith">Kent A. Griffith</name>
</author>
<author>
<name sortKey="Arora, Alisha" sort="Arora, Alisha" uniqKey="Arora A" first="Alisha" last="Arora">Alisha Arora</name>
</author>
<author>
<name sortKey="Shargorodsky, Josef" sort="Shargorodsky, Josef" uniqKey="Shargorodsky J" first="Josef" last="Shargorodsky">Josef Shargorodsky</name>
</author>
<author>
<name sortKey="Blazer, Dan G" sort="Blazer, Dan G" uniqKey="Blazer D" first="Dan G" last="Blazer">Dan G. Blazer</name>
</author>
<author>
<name sortKey="Rees, Riley" sort="Rees, Riley" uniqKey="Rees R" first="Riley" last="Rees">Riley Rees</name>
</author>
<author>
<name sortKey="Wong, Sandra L" sort="Wong, Sandra L" uniqKey="Wong S" first="Sandra L" last="Wong">Sandra L. Wong</name>
</author>
<author>
<name sortKey="Cimmino, Vincent M" sort="Cimmino, Vincent M" uniqKey="Cimmino V" first="Vincent M" last="Cimmino">Vincent M. Cimmino</name>
</author>
<author>
<name sortKey="Chang, Alfred E" sort="Chang, Alfred E" uniqKey="Chang A" first="Alfred E" last="Chang">Alfred E. Chang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17560249</idno>
<idno type="pmid">17560249</idno>
<idno type="doi">10.1016/j.surg.2006.12.018</idno>
<idno type="wicri:Area/PubMed/Corpus">003619</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003619</idno>
<idno type="wicri:Area/PubMed/Curation">003619</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003619</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.</title>
<author>
<name sortKey="Sabel, Michael S" sort="Sabel, Michael S" uniqKey="Sabel M" first="Michael S" last="Sabel">Michael S. Sabel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Surgical Oncology, Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.msabel@umich.edu </nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Division of Surgical Oncology, Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Griffith, Kent A" sort="Griffith, Kent A" uniqKey="Griffith K" first="Kent A" last="Griffith">Kent A. Griffith</name>
</author>
<author>
<name sortKey="Arora, Alisha" sort="Arora, Alisha" uniqKey="Arora A" first="Alisha" last="Arora">Alisha Arora</name>
</author>
<author>
<name sortKey="Shargorodsky, Josef" sort="Shargorodsky, Josef" uniqKey="Shargorodsky J" first="Josef" last="Shargorodsky">Josef Shargorodsky</name>
</author>
<author>
<name sortKey="Blazer, Dan G" sort="Blazer, Dan G" uniqKey="Blazer D" first="Dan G" last="Blazer">Dan G. Blazer</name>
</author>
<author>
<name sortKey="Rees, Riley" sort="Rees, Riley" uniqKey="Rees R" first="Riley" last="Rees">Riley Rees</name>
</author>
<author>
<name sortKey="Wong, Sandra L" sort="Wong, Sandra L" uniqKey="Wong S" first="Sandra L" last="Wong">Sandra L. Wong</name>
</author>
<author>
<name sortKey="Cimmino, Vincent M" sort="Cimmino, Vincent M" uniqKey="Cimmino V" first="Vincent M" last="Cimmino">Vincent M. Cimmino</name>
</author>
<author>
<name sortKey="Chang, Alfred E" sort="Chang, Alfred E" uniqKey="Chang A" first="Alfred E" last="Chang">Alfred E. Chang</name>
</author>
</analytic>
<series>
<title level="j">Surgery</title>
<idno type="ISSN">0039-6060</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Body Mass Index</term>
<term>Female</term>
<term>Groin</term>
<term>Humans</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphedema (etiology)</term>
<term>Male</term>
<term>Melanoma (diagnosis)</term>
<term>Melanoma (pathology)</term>
<term>Melanoma (secondary)</term>
<term>Melanoma (surgery)</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Palpation</term>
<term>Retrospective Studies</term>
<term>Risk Assessment</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Skin Neoplasms (pathology)</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aine</term>
<term>Analyse de survie</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de masse corporelle</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Mélanome ()</term>
<term>Mélanome (anatomopathologie)</term>
<term>Mélanome (diagnostic)</term>
<term>Mélanome (secondaire)</term>
<term>Palpation</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
<term>Études rétrospectives</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Mélanome</term>
<term>Tumeurs cutanées</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Melanoma</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Mélanome</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="secondaire" xml:lang="fr">
<term>Mélanome</term>
</keywords>
<keywords scheme="MESH" qualifier="secondary" xml:lang="en">
<term>Melanoma</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Melanoma</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Body Mass Index</term>
<term>Female</term>
<term>Groin</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Palpation</term>
<term>Retrospective Studies</term>
<term>Risk Assessment</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aine</term>
<term>Analyse de survie</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de masse corporelle</term>
<term>Mâle</term>
<term>Mélanome</term>
<term>Palpation</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">With the introduction of sentinel lymph node (SLN) biopsy for melanoma, inguinal lymph node dissections (ILND) are more commonly performed for microscopic disease than for clinically palpable disease. We sought to examine the effect this change has on the morbidity of the operation.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17560249</PMID>
<DateCreated>
<Year>2007</Year>
<Month>06</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>07</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>06</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0039-6060</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>141</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2007</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Surgery</Title>
<ISOAbbreviation>Surgery</ISOAbbreviation>
</Journal>
<ArticleTitle>Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.</ArticleTitle>
<Pagination>
<MedlinePgn>728-35</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">With the introduction of sentinel lymph node (SLN) biopsy for melanoma, inguinal lymph node dissections (ILND) are more commonly performed for microscopic disease than for clinically palpable disease. We sought to examine the effect this change has on the morbidity of the operation.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective review was performed of all patients who underwent an ILND for melanoma between October 1997 and April, 2006. Clinical and pathologic data were collected and correlated by multivariate analysis with the incidence of a major wound complication.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 212 patients, 132 who underwent an ILND for a positive SLN and 80 for clinically palpable disease. Age, sex, and body mass index (BMI) were similar in both groups. Patients with clinically palpable disease had a significantly greater number of involved nodes (3.0 vs 1.96, P = .0013), more often had >or=4 involved nodes (29% vs 9%, P < .001), and a greater incidence of extranodal extension (47% vs 5%, P < .001). Of the 212 patients, 41 (19%) had a significant wound complication. This complication was significantly higher among patients with clinical disease compared to patients with a positive SLN (28% vs 14%, P = .02). Only BMI (odds ratio of 1.1) and the indication for the procedure (odds ratio of 2.2) were independent predictors of a major wound complication. Lymphedema occurred in 30% of the patients and was only significantly associated with clinical disease (41% vs 24%, P = .025). With a median follow-up of 2 years, regional recurrence was not significantly greater in patients with clinically palpable disease (13% vs 9%, P = not significant [ns]), although this result was possibly due to the significantly greater rate of distant recurrence (49% vs 18%, P < .001) and death (48% vs 21%) in these patients.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients undergoing an ILND for a positive SLN have a significantly lower risk of postoperative complication or lymphedema than do patients undergoing ILND for clinically palpable disease. There is a benefit in regard to the morbidity of treatment in surgically staging melanoma patients by SLN biopsy and preventing ILND for palpable disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sabel</LastName>
<ForeName>Michael S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Division of Surgical Oncology, Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.msabel@umich.edu </Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Griffith</LastName>
<ForeName>Kent A</ForeName>
<Initials>KA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arora</LastName>
<ForeName>Alisha</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shargorodsky</LastName>
<ForeName>Josef</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Blazer</LastName>
<ForeName>Dan G</ForeName>
<Initials>DG</Initials>
<Suffix>3rd</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Rees</LastName>
<ForeName>Riley</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Sandra L</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cimmino</LastName>
<ForeName>Vincent M</ForeName>
<Initials>VM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Alfred E</ForeName>
<Initials>AE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Surgery</MedlineTA>
<NlmUniqueID>0417347</NlmUniqueID>
<ISSNLinking>0039-6060</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006119" MajorTopicYN="Y">Groin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010173" MajorTopicYN="N">Palpation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021701" MajorTopicYN="Y">Sentinel Lymph Node Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2006</Year>
<Month>07</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2006</Year>
<Month>12</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2006</Year>
<Month>12</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>7</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17560249</ArticleId>
<ArticleId IdType="pii">S0039-6060(07)00091-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.surg.2006.12.018</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003619 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003619 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:17560249
   |texte=   Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:17560249" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024